The Level of Estrogen and Progesterone Receptor Immunoreactivity Correlates With Time to Disease Recurrence in Hormone Receptor-Positive Breast Cancer

被引：0
|
作者：
Winner, Megan [1 ]
Rosman, Martin [2 ]
Mylander, Charles [2 ]
Jackson, Rubie Sue [2 ]
Pozo, Marcos [1 ]
Umbricht, Christopher [3 ]
Tafra, Lorraine [2 ]
机构：
[1] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[2] Anne Arundel Med Ctr, Annapolis, MD USA
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2016年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0235
引用
收藏
页码：171 / 172
页数：2
相关论文
共 50 条
  • [41] Does estrogen receptor-negative/progesterone receptor-positive breast carcinoma exist?
    De Maeyer, Leen
    Van Limbergen, Erik
    De Nys, Katelijne
    Moerman, Philippe
    Pochet, Nathalie
    Hendrickx, Wouter
    Wildiers, Hans
    Paridaens, Robert
    Smeets, Ann
    Christiaens, Marie-Rose
    Vergote, Ignace
    Leunen, Karin
    Amant, Frederic
    Neven, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) : 335 - 336
  • [42] Association between sociodemographic factors and estrogen receptor-positive, progesterone receptor-positive breast cancer subtypes: A cross-sectional study
    Mugada, Vinodkumar
    Kolakota, Raj Kiran
    Mahato, Varsha
    MAKARA JOURNAL OF HEALTH RESEARCH, 2020, 24 (02): : 84 - 90
  • [43] TUMOR-PROLIFERATIVE ACTIVITY, PROGESTERONE-RECEPTOR STATUS, ESTROGEN-RECEPTOR LEVEL, AND CLINICAL OUTCOME OF ESTROGEN RECEPTOR-POSITIVE ADVANCED BREAST-CANCER
    PARADISO, A
    TOMMASI, S
    MANGIA, A
    LORUSSO, V
    SIMONE, G
    DELENA, M
    CANCER RESEARCH, 1990, 50 (10) : 2958 - 2962
  • [44] The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer
    Hickey, Theresa E.
    Selth, Luke A.
    Chia, Kee Ming
    Laven-Law, Geraldine
    Milioli, Heloisa H.
    Roden, Daniel
    Jindal, Shalini
    Hui, Mun
    Finlay-Schultz, Jessica
    Ebrahimie, Esmaeil
    Birrell, Stephen N.
    Stelloo, Suzan
    Iggo, Richard
    Alexandrou, Sarah
    Caldon, C. Elizabeth
    Abdel-Fatah, Tarek M.
    Ellis, Ian O.
    Zwart, Wilbert
    Palmieri, Carlo
    Sartorius, Carol A.
    Swarbrick, Alex
    Lim, Elgene
    Carroll, Jason S.
    Tilley, Wayne D.
    NATURE MEDICINE, 2021, 27 (02) : 310 - +
  • [45] Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer.
    Ma, Sung Jun
    Gill, Jasmin
    Yendamuri, Keerti
    Yu, Brian
    Yao, Song
    Oladeru, Oluwadamilola Temilade
    Singh, Anurag K.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [46] New Strategies in Estrogen Receptor-Positive Breast Cancer
    Johnston, Stephen R. D.
    CLINICAL CANCER RESEARCH, 2010, 16 (07) : 1979 - 1987
  • [47] Geographic excess of estrogen receptor-positive breast cancer
    Benz, CC
    Clarke, CA
    Moore, DH
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (12) : 1523 - 1527
  • [48] Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer
    Chan, Melissa
    Chang, Martin C.
    Gonzalez, Rosa
    Lategan, Belinda
    del Barco, Elvira
    Vera-Badillo, Francisco
    Quesada, Paula
    Goldstein, Robyn
    Cruz, Ignacio
    Ocana, Alberto
    Cruz, Juan J.
    Amir, Eitan
    PLOS ONE, 2015, 10 (07):
  • [49] Estrogen receptor-positive breast cancer: a multidisciplinary challenge
    Zwart, Wilbert
    Theodorou, Vasiliki
    Carroll, Jason S.
    WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE, 2011, 3 (02) : 216 - 230
  • [50] Risk factors for estrogen receptor-positive breast cancer
    Hwang, ES
    Chew, T
    Shiboski, S
    Farren, G
    Benz, CC
    Wrensch, M
    ARCHIVES OF SURGERY, 2005, 140 (01) : 58 - 62
12345